ResearcherSichuan UniversityActive in the last 2 years
Yongjie Zhu
Matched on ORCID iD 0000-0002-8714-2647; OpenAlex author ID A5031414341. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2024: 1 paper · 2025: 2 papers
Papers 3
- Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume… Co-author DOI 10.1016/j.tranon.2024.102252↗
- CSF1-CAR Specifically Targets CSF1R + Pancreatic Cancer Cells and Tumor-Associated Macrophages. Co-author DOI 10.1097/cji.0000000000000563↗
- Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. Co-author DOI 10.1016/j.tranon.2023.101803↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xudong Zhao · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Yuncang Yuan · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Xu Wei Luo · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Jiawei Fan · 1 shared paper, 2025 · strength 0.33
- Bin Sun · 1 shared paper, 2025 · strength 0.33
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.